Voya Investment Management LLC Durect Corp Transaction History

Voya Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.64 $35,055 - $59,040	-92,250 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.9 - $1.31 $292 - $425	-325 Reduced 0.35%	92,250 $91,000
Q4 2020 Feb 16, 2021	BUY	$1.65 - $2.43 $38,393 - $56,543	23,269 Added 33.57%	92,575 $192,000
Q2 2020 Aug 14, 2020	BUY	$1.33 - $2.76 $92,176 - $191,284	69,306 New	69,306 $161,000
Q2 2019 Aug 14, 2019	SELL	$0.51 - $0.86 $31,189 - $52,594	-61,156 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$1.56 - $2.51 $14,391 - $23,154	-9,225 Reduced 13.11%	61,156 $95,000
Q1 2018 May 15, 2018	SELL	$0.91 - $2.24 $11,324 - $27,876	-12,445 Reduced 15.03%	70,381 $151,000
Q3 2017 Nov 14, 2017	BUY	$1.55 - $1.82 $128,380 - $150,743	82,826	82,826 $147,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $223M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.